Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
ImmunityBio, the developer of bladder cancer treatment Anktiva, is accused by the U.S. Food and Drug Administration of disseminating “false or misleading information” about the drug's efficacy in an advertisement and podcast. The FDA said it’s not the first time it's sent a warning letter to the company’s executives over allegedly inaccurate claims.
San Diego-based Turquoise Health was founded in 2020 and has evolved to be a healthcare pricing engine used to develop health plan networks and contract rates. The company said its end goal is complete price transparency to make it easier for all organizations and patients to navigate the U.S. healthcare system.
The two not-for-profit health systems announced the merger on Wednesday. Although the deal won’t be finalized for some time, they teased new investments that will bring 39 hospitals and more than 400 primary and specialty care sites under the banner of a new Sutter Health.
The problem is limited to surgical stapler reloads used by the da Vinci robot, specifically those manufactured by Intuitive Surgical. The FDA said it’s currently investigating why the reloads are leaving incomplete line formations. For now, they need to be pulled from all patient care settings.
A therapeutic oncology company has been cleared to market a cancer treatment that that turns a tumor’s own biology into a self-signaling target for radiation therapy.
Whatever specific shape work takes in the near and distant future, it’s likely the COVID-19 era will be looked back upon as a before-and-after dividing line.
Clarius Mobile Health of Vancouver, B.C., has won FDA approval to market an AI model that works with the company’s handheld point-of-care ultrasound devices to identify and measure tendons of the foot, ankle and knee.
Our monthly review of FDA-related news items in the world of cardiology includes updates from CardiacSense, MedAlliance, Lupin, Realize Medical and Eli Lilly and Company.
The FDA has cleared U.K.-based Adaptix to market a 3D X-ray system that, according to the company, images hands, feet and elbows “at a fraction of the radiation dose and per-study cost of traditional CT.”
The latest findings highlight the worsening crisis of burnout among U.S. clinicians, who have frequently cited the COVID-19 pandemic as a major impact.